Jeil Pharmaceutical Co Ltd (271980) - Financial and Strategic SWOT Analysis Review

October 2021 | 37 pages | ID: J3B30106520EN
GlobalData

Abstracts

Jeil Pharmaceutical Co Ltd (271980) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Jeil Pharmaceutical Co Ltd (Jeil), is a pharmaceutical company which carries out research, development, manufacturing and commercialization of active pharmaceuticals and finished dosage forms. Its product portfolio includes solid medicines and injections, finished pharmaceutical products including patches and active pharmaceutical ingredients (APIs). The company offers APIs in the therapeutic areas of antibiotic, oncology, cardiovascular, urology, gastrointestinal, antiviral and respiratory, among others. Jeil exports synthetic ingredients such as Cefditoren Pivoxil and Epinastine HCl, among others to Japan and China. It also exports over the counter products such as Kefentech Plaster and Sanyplast in ASEAN countries, Central and South America, Africa, and other countries. The company operates a factory and research and development institute in Yongin-si, Gyeonggi-do, Korea. Jeil is headquartered in Seoul, South Korea.

Jeil Pharmaceutical Co Ltd Key Recent Developments

May 21,2021: Jeil Pharmaceutical established Onconic Therapeutics, a company specializing in R&D

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Jeil Pharmaceutical Co Ltd - Key Facts
Jeil Pharmaceutical Co Ltd - Key Employees
Jeil Pharmaceutical Co Ltd - Major Products and Services
Jeil Pharmaceutical Co Ltd - History
Jeil Pharmaceutical Co Ltd - Company Statement
Jeil Pharmaceutical Co Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Jeil Pharmaceutical Co Ltd - Business Description
Jeil Pharmaceutical Co Ltd - SWOT Analysis
SWOT Analysis - Overview
Jeil Pharmaceutical Co Ltd - Strengths
Jeil Pharmaceutical Co Ltd - Weaknesses
Jeil Pharmaceutical Co Ltd - Opportunities
Jeil Pharmaceutical Co Ltd - Threats
Jeil Pharmaceutical Co Ltd - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Jeil Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Jeil Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Jeil Pharmaceutical Co Ltd, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

May 21, 2021: Jeil Pharmaceutical established Onconic Therapeutics, a company specializing in R&D

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Jeil Pharmaceutical Co Ltd, Key Facts
Jeil Pharmaceutical Co Ltd, Key Employees
Jeil Pharmaceutical Co Ltd, Major Products and Services
Jeil Pharmaceutical Co Ltd, History
Jeil Pharmaceutical Co Ltd, Other Locations
Jeil Pharmaceutical Co Ltd, Subsidiaries
Jeil Pharmaceutical Co Ltd, Key Competitors
Jeil Pharmaceutical Co Ltd, Ratios based on current share price
Jeil Pharmaceutical Co Ltd, Annual Ratios
Jeil Pharmaceutical Co Ltd, Annual Ratios (Cont...1)
Jeil Pharmaceutical Co Ltd, Annual Ratios (Cont...2)
Jeil Pharmaceutical Co Ltd, Interim Ratios
Jeil Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Jeil Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Jeil Pharmaceutical Co Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Jeil Pharmaceutical Co Ltd, Performance Chart (2017 - 2020)
Jeil Pharmaceutical Co Ltd, Ratio Charts
Jeil Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Jeil Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021